Most recent by Valerie Raney, PharmD
SPONSORED CONTENT
September 25, 2011
6 min read
Save
Ticagrelor: A review of the data leading to FDA approval
The thienopyridines clopidogrel and ticlopidine, along with aspirin, have been the mainstay of antiplatelet therapy in patients with acute coronary syndromes.
SPONSORED CONTENT
September 01, 2011
4 min read
Save
Ticagrelor: A review of the data leading to FDA approval
The thienopyridines clopidogrel and ticlopidine, along with aspirin, have been the mainstay of antiplatelet therapy in patients with acute coronary syndromes.